| Dr Belin Fred Bodie, MD | |
|
4300 Old Shell Rd, Ste B, Mobile, AL 36608-2036 | |
| (251) 342-7880 | |
| (251) 342-8369 |
| Full Name | Dr Belin Fred Bodie |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 50 Years |
| Location | 4300 Old Shell Rd, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891798807 | NPI | - | NPPES |
| 00004869 | Medicaid | AL | |
| 51004869 | Other | AL | BLUE CROSS BLUE SHIELD OF AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 6998 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of South Alabama Health Care Authority | 4082986088 | 107 |
News Archive
Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.
The Inserm team led by Guillaume Duménil at the Institut Pasteur, in collaboration with several teams of physicists, has unraveled a key stage in infection by Neisseria meningitidis, a human pathogen responsible for meningitis in infants and young adults.
How a pandemic progresses in a country is largely determined by social, political and psychological processes. Predicting these socio-dynamics seems hardly possible until today; thus making it impossible to foresee the course the pandemic takes.
Scientists are reporting development of a simple new procedure for removing almost 98 percent of an important impurity that can contaminate prescription drugs and potentially increase the risk for adverse health effects in patients.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 3 days ago
| Entity Name | University Of South Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508392432 PECOS PAC ID: 4082986088 Enrollment ID: O20170825003180 |
News Archive
Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.
The Inserm team led by Guillaume Duménil at the Institut Pasteur, in collaboration with several teams of physicists, has unraveled a key stage in infection by Neisseria meningitidis, a human pathogen responsible for meningitis in infants and young adults.
How a pandemic progresses in a country is largely determined by social, political and psychological processes. Predicting these socio-dynamics seems hardly possible until today; thus making it impossible to foresee the course the pandemic takes.
Scientists are reporting development of a simple new procedure for removing almost 98 percent of an important impurity that can contaminate prescription drugs and potentially increase the risk for adverse health effects in patients.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Belin Fred Bodie, MD 4300 Old Shell Rd, Ste B, Mobile, AL 36608-2036 Ph: (251) 342-7880 | Dr Belin Fred Bodie, MD 4300 Old Shell Rd, Ste B, Mobile, AL 36608-2036 Ph: (251) 342-7880 |
News Archive
Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.
The Inserm team led by Guillaume Duménil at the Institut Pasteur, in collaboration with several teams of physicists, has unraveled a key stage in infection by Neisseria meningitidis, a human pathogen responsible for meningitis in infants and young adults.
How a pandemic progresses in a country is largely determined by social, political and psychological processes. Predicting these socio-dynamics seems hardly possible until today; thus making it impossible to foresee the course the pandemic takes.
Scientists are reporting development of a simple new procedure for removing almost 98 percent of an important impurity that can contaminate prescription drugs and potentially increase the risk for adverse health effects in patients.
With the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting over 50 million people worldwide with hundreds of thousands experiencing severe respiratory illness, researchers have been trying to find the factors associated with severe disease. From the start of the pandemic in March this year, several studies have indicated heart disease, high blood pressure, diabetes, obesity, etc. could be linked to severe disease. Now German researchers have published a study on the association between severe respiratory infection caused by SARS CoV-2 and factors such as age, body mass index (BMI) and ABO blood group.
› Verified 3 days ago
Dr. Dena Jones Howell, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4310 Old Shell Rd, Suite D, Mobile, AL 36608 Phone: 251-343-9100 Fax: 251-343-9125 | |
Virginia Jones Reeder, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E, 2nd Floor, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572 | |
Dr. John Scott Vanloock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6163 Omni Park Dr, Mobile, AL 36609 Phone: 251-635-1315 Fax: 251-635-1210 | |
Dr. Robert Neil Capper, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 5317 Oak Bend Ct, Mobile, AL 36609 Phone: 251-661-3200 | |
Aldo Trovato, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3715 Dauphin Street Building 2, 4th Floor, Mobile, AL 36608 Phone: 251-343-2100 Fax: 251-344-9944 | |
Dr. Ryan Burke Ramagosa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 70 Midtown Park E, Mobile, AL 36606 Phone: 251-289-1786 | |
Dr. Cary L. Dunn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E Fl 2, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572 |